ID   BIRC6_HUMAN             Reviewed;        4857 AA.
AC   Q9NR09; Q9ULD1;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 2.
DT   10-MAY-2017, entry version 156.
DE   RecName: Full=Baculoviral IAP repeat-containing protein 6;
DE            EC=2.3.2.27 {ECO:0000269|PubMed:14765125, ECO:0000269|PubMed:18329369};
DE   AltName: Full=BIR repeat-containing ubiquitin-conjugating enzyme;
DE            Short=BRUCE;
DE   AltName: Full=RING-type E3 ubiquitin transferase BIRC6 {ECO:0000305};
DE   AltName: Full=Ubiquitin-conjugating BIR domain enzyme apollon;
DE            Short=APOLLON;
GN   Name=BIRC6; Synonyms=KIAA1289;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 29-4857.
RC   TISSUE=Brain;
RX   PubMed=10544019; DOI=10.1006/bbrc.1999.1585;
RA   Chen Z., Naito M., Hori S., Mashima T., Yamori T., Tsuruo T.;
RT   "A human IAP-family gene, apollon, expressed in human brain cancer
RT   cells.";
RL   Biochem. Biophys. Res. Commun. 264:847-854(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2063-4857.
RC   TISSUE=Brain;
RX   PubMed=10574462; DOI=10.1093/dnares/6.5.337;
RA   Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:337-345(1999).
RN   [4]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [5]
RP   INTERACTION WITH RNF41, UBIQUITINATION, FUNCTION, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=14765125; DOI=10.1038/sj.emboj.7600075;
RA   Qiu X.B., Markant S.L., Yuan J., Goldberg A.L.;
RT   "Nrdp1-mediated degradation of the gigantic IAP, BRUCE, is a novel
RT   pathway for triggering apoptosis.";
RL   EMBO J. 23:800-810(2004).
RN   [6]
RP   FUNCTION, SUBUNIT, ENZYME REGULATION, DOMAIN BIR, AND INTERACTION WITH
RP   HTRA2; CASP3; CASP6; CASP7; CASP9 AND DIABLO/SMAC.
RX   PubMed=15200957; DOI=10.1016/j.molcel.2004.05.018;
RA   Bartke T., Pohl C., Pyrowolakis G., Jentsch S.;
RT   "Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3
RT   ubiquitin ligase.";
RL   Mol. Cell 14:801-811(2004).
RN   [7]
RP   REVIEW ON FUNCTION.
RX   PubMed=15340445; DOI=10.1038/ncb0904-804;
RA   Martin S.J.;
RT   "An Apollon vista of death and destruction.";
RL   Nat. Cell Biol. 6:804-806(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, PHOSPHORYLATION,
RP   UBIQUITINATION, DEUBIQUITINATION, AND INTERACTION WITH KIF23/MKLP1;
RP   USP8/UBPY; BIRC5/SURVIVIN; MAP2K1/MEK1; RAB8A/RAB8; RAB11A/RAB11;
RP   PLK1; EXOC3/SEC6 AND EXOC4/SEC8.
RX   PubMed=18329369; DOI=10.1016/j.cell.2008.01.012;
RA   Pohl C., Jentsch S.;
RT   "Final stages of cytokinesis and midbody ring formation are controlled
RT   by BRUCE.";
RL   Cell 132:832-845(2008).
RN   [10]
RP   REVIEW ON FUNCTION.
RX   PubMed=18414036; DOI=10.4161/cc.7.8.5783;
RA   Dubrez-Daloz L., Dupoux A., Cartier J.;
RT   "IAPs: more than just inhibitors of apoptosis proteins.";
RL   Cell Cycle 7:1036-1046(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-480, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-480, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-480, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-480; SER-581; SER-590;
RP   SER-2222; SER-2955; THR-3931 AND SER-4023, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-480 AND THR-1710, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.01 ANGSTROMS) OF 4498-4820.
RG   Structural genomics consortium (SGC);
RT   "Ubc domain of the ubiquitin-protein ligase baculoviral IAP repeat-
RT   containing protein 6.";
RL   Submitted (APR-2008) to the PDB data bank.
CC   -!- FUNCTION: Anti-apoptotic protein which can regulate cell death by
CC       controlling caspases and by acting as an E3 ubiquitin-protein
CC       ligase. Has an unusual ubiquitin conjugation system in that it
CC       could combine in a single polypeptide, ubiquitin conjugating (E2)
CC       with ubiquitin ligase (E3) activity, forming a chimeric E2/E3
CC       ubiquitin ligase. Its tragets include CASP9 and DIABLO/SMAC. Acts
CC       as an inhibitor of CASP3, CASP7 and CASP9. Important regulator for
CC       the final stages of cytokinesis. Crucial for normal vesicle
CC       targeting to the site of abscission, but also for the integrity of
CC       the midbody and the midbody ring, and its striking ubiquitin
CC       modification. {ECO:0000269|PubMed:14765125,
CC       ECO:0000269|PubMed:15200957, ECO:0000269|PubMed:18329369}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000269|PubMed:14765125,
CC       ECO:0000269|PubMed:18329369}.
CC   -!- ENZYME REGULATION: Inhibited by DIABLO/SMAC, HTRA2, CASP3, CASP6,
CC       CASP7 and CASP9. {ECO:0000269|PubMed:15200957}.
CC   -!- SUBUNIT: Homodimer. Binds the activated, processed forms of CASP3,
CC       CASP6, CASP7 and CASP9. Interacts with RNF41, DIABLO/SMAC, HTRA2,
CC       KIF23/MKLP1, USP8/UBPY, BIRC5/survivin, MAP2K1/MEK1, RAB8A/RAB8,
CC       RAB11A/RAB11, PLK1, EXOC3/SEC6 and EXOC4/SEC8.
CC       {ECO:0000269|PubMed:14765125, ECO:0000269|PubMed:15200957,
CC       ECO:0000269|PubMed:18329369}.
CC   -!- INTERACTION:
CC       Q96A65:EXOC4; NbExp=3; IntAct=EBI-1765160, EBI-355383;
CC       Q02241:KIF23; NbExp=4; IntAct=EBI-1765160, EBI-306852;
CC       Q02750:MAP2K1; NbExp=2; IntAct=EBI-1765160, EBI-492564;
CC       P53350:PLK1; NbExp=4; IntAct=EBI-1765160, EBI-476768;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network
CC       membrane {ECO:0000269|PubMed:18329369}. Midbody
CC       {ECO:0000269|PubMed:18329369}. Endosome
CC       {ECO:0000269|PubMed:18329369}. Cytoplasm, cytoskeleton, spindle
CC       pole {ECO:0000269|PubMed:18329369}. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:18329369}. Note=Concentrates in a
CC       pericentriolar compartment in interphase, moves partially to
CC       spindle poles in metaphase, and finally localizes to the spindle
CC       midzone and the midbody in telophase and during cytokinesis.
CC   -!- TISSUE SPECIFICITY: Expressed in brain cancer cells.
CC   -!- DOMAIN: The BIR domain is essential for its antiapoptotic function
CC       and is important for binding to DIABLO/SMAC and CASP9.
CC       {ECO:0000269|PubMed:15200957}.
CC   -!- PTM: Ubiquitinated. Ubiquitination is mediated by the RNF41 E3
CC       ligase and leads to proteasomal degradation, impairing inhibition
CC       of apoptosis. Deubiquitinated by USP8/UBPY.
CC       {ECO:0000269|PubMed:14765125, ECO:0000269|PubMed:18329369}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the ubiquitin-
CC       conjugating enzyme family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA86603.2; Type=Frameshift; Positions=2047; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/BIRC6ID798ch2p22.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC079837; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133243; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133245; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133246; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF265555; AAF75772.1; -; mRNA.
DR   EMBL; AB033115; BAA86603.2; ALT_FRAME; mRNA.
DR   CCDS; CCDS33175.2; -.
DR   RefSeq; NP_057336.3; NM_016252.3.
DR   UniGene; Hs.150107; -.
DR   PDB; 3CEG; X-ray; 2.01 A; A/B=4498-4820.
DR   PDBsum; 3CEG; -.
DR   ProteinModelPortal; Q9NR09; -.
DR   SMR; Q9NR09; -.
DR   BioGrid; 121521; 58.
DR   IntAct; Q9NR09; 19.
DR   STRING; 9606.ENSP00000393596; -.
DR   MEROPS; I32.006; -.
DR   iPTMnet; Q9NR09; -.
DR   PhosphoSitePlus; Q9NR09; -.
DR   BioMuta; BIRC6; -.
DR   DMDM; 313104079; -.
DR   EPD; Q9NR09; -.
DR   MaxQB; Q9NR09; -.
DR   PaxDb; Q9NR09; -.
DR   PeptideAtlas; Q9NR09; -.
DR   PRIDE; Q9NR09; -.
DR   Ensembl; ENST00000421745; ENSP00000393596; ENSG00000115760.
DR   GeneID; 57448; -.
DR   KEGG; hsa:57448; -.
DR   UCSC; uc010ezu.4; human.
DR   CTD; 57448; -.
DR   DisGeNET; 57448; -.
DR   GeneCards; BIRC6; -.
DR   H-InvDB; HIX0001957; -.
DR   H-InvDB; HIX0030282; -.
DR   HGNC; HGNC:13516; BIRC6.
DR   HPA; HPA074409; -.
DR   HPA; HPA074738; -.
DR   MIM; 605638; gene.
DR   neXtProt; NX_Q9NR09; -.
DR   PharmGKB; PA25363; -.
DR   eggNOG; KOG0895; Eukaryota.
DR   eggNOG; KOG1101; Eukaryota.
DR   eggNOG; ENOG410XP8C; LUCA.
DR   HOGENOM; HOG000168828; -.
DR   HOVERGEN; HBG050691; -.
DR   InParanoid; Q9NR09; -.
DR   KO; K10586; -.
DR   OrthoDB; EOG091G0T73; -.
DR   PhylomeDB; Q9NR09; -.
DR   TreeFam; TF105357; -.
DR   SignaLink; Q9NR09; -.
DR   SIGNOR; Q9NR09; -.
DR   ChiTaRS; BIRC6; human.
DR   EvolutionaryTrace; Q9NR09; -.
DR   GeneWiki; BIRC6; -.
DR   GenomeRNAi; 57448; -.
DR   PRO; PR:Q9NR09; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115760; -.
DR   CleanEx; HS_BIRC6; -.
DR   ExpressionAtlas; Q9NR09; baseline and differential.
DR   Genevisible; Q9NR09; HS.
DR   GO; GO:0005768; C:endosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005815; C:microtubule organizing center; IDA:UniProtKB.
DR   GO; GO:0030496; C:midbody; IDA:UniProtKB.
DR   GO; GO:0000922; C:spindle pole; IDA:UniProtKB.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:UniProtKB.
DR   GO; GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IMP:UniProtKB.
DR   GO; GO:0061631; F:ubiquitin conjugating enzyme activity; IEA:Ensembl.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0060711; P:labyrinthine layer development; IEA:Ensembl.
DR   GO; GO:0007067; P:mitotic nuclear division; IEA:UniProtKB-KW.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell proliferation; TAS:UniProtKB.
DR   GO; GO:0032465; P:regulation of cytokinesis; IMP:UniProtKB.
DR   GO; GO:0060712; P:spongiotrophoblast layer development; IEA:Ensembl.
DR   CDD; cd00022; BIR; 1.
DR   CDD; cd00195; UBCc; 1.
DR   Gene3D; 2.60.120.260; -; 1.
DR   Gene3D; 3.10.110.10; -; 1.
DR   InterPro; IPR001370; BIR_rpt.
DR   InterPro; IPR022103; BIRC6.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR000608; UBQ-conjugat_E2.
DR   InterPro; IPR016135; UBQ-conjugating_enzyme/RWD.
DR   Pfam; PF00653; BIR; 1.
DR   Pfam; PF12356; BIRC6; 1.
DR   Pfam; PF00179; UQ_con; 1.
DR   SMART; SM00238; BIR; 1.
DR   SUPFAM; SSF54495; SSF54495; 1.
DR   PROSITE; PS50143; BIR_REPEAT_2; 1.
DR   PROSITE; PS50127; UBIQUITIN_CONJUGAT_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; Cell cycle; Cell division; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Endosome; Golgi apparatus; Membrane; Mitosis;
KW   Phosphoprotein; Protease inhibitor; Reference proteome;
KW   Thiol protease inhibitor; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway.
FT   CHAIN         1   4857       Baculoviral IAP repeat-containing protein
FT                                6.
FT                                /FTId=PRO_0000122361.
FT   REPEAT      284    358       BIR.
FT   REGION     4576   4704       Ubiquitin-conjugating.
FT   COMPBIAS     30     36       Poly-Ala.
FT   COMPBIAS   1660   1668       Poly-Ala.
FT   ACT_SITE   4625   4625       Glycyl thioester intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00388}.
FT   MOD_RES     473    473       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88738}.
FT   MOD_RES     480    480       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     482    482       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88738}.
FT   MOD_RES     581    581       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     590    590       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1710   1710       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    2222   2222       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2955   2955       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    3931   3931       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    4023   4023       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CONFLICT   1332   1332       V -> L (in Ref. 2; AAF75772).
FT                                {ECO:0000305}.
FT   CONFLICT   2319   2319       L -> F (in Ref. 3; BAA86603).
FT                                {ECO:0000305}.
FT   CONFLICT   2674   2674       T -> S (in Ref. 2; AAF75772).
FT                                {ECO:0000305}.
FT   HELIX      4524   4533       {ECO:0000244|PDB:3CEG}.
FT   STRAND     4536   4540       {ECO:0000244|PDB:3CEG}.
FT   STRAND     4543   4545       {ECO:0000244|PDB:3CEG}.
FT   STRAND     4551   4555       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4560   4564       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4572   4588       {ECO:0000244|PDB:3CEG}.
FT   STRAND     4597   4604       {ECO:0000244|PDB:3CEG}.
FT   STRAND     4608   4615       {ECO:0000244|PDB:3CEG}.
FT   STRAND     4625   4631       {ECO:0000244|PDB:3CEG}.
FT   TURN       4634   4638       {ECO:0000244|PDB:3CEG}.
FT   STRAND     4642   4645       {ECO:0000244|PDB:3CEG}.
FT   TURN       4649   4652       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4668   4670       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4677   4679       {ECO:0000244|PDB:3CEG}.
FT   TURN       4683   4685       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4688   4698       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4704   4707       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4711   4714       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4718   4738       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4741   4745       {ECO:0000244|PDB:3CEG}.
FT   TURN       4749   4751       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4752   4777       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4788   4810       {ECO:0000244|PDB:3CEG}.
SQ   SEQUENCE   4857 AA;  530255 MW;  0F5939F9C40F4270 CRC64;
     MVTGGGAAPP GTVTEPLPSV IVLSAGRKMA AAAAAASGPG CSSAAGAGAA GVSEWLVLRD
     GCMHCDADGL HSLSYHPALN AILAVTSRGT IKVIDGTSGA TLQASALSAK PGGQVKCQYI
     SAVDKVIFVD DYAVGCRKDL NGILLLDTAL QTPVSKQDDV VQLELPVTEA QQLLSACLEK
     VDISSTEGYD LFITQLKDGL KNTSHETAAN HKVAKWATVT FHLPHHVLKS IASAIVNELK
     KINQNVAALP VASSVMDRLS YLLPSARPEL GVGPGRSVDR SLMYSEANRR ETFTSWPHVG
     YRWAQPDPMA QAGFYHQPAS SGDDRAMCFT CSVCLVCWEP TDEPWSEHER HSPNCPFVKG
     EHTQNVPLSV TLATSPAQFP CTDGTDRISC FGSGSCPHFL AAATKRGKIC IWDVSKLMKV
     HLKFEINAYD PAIVQQLILS GDPSSGVDSR RPTLAWLEDS SSCSDIPKLE GDSDDLLEDS
     DSEEHSRSDS VTGHTSQKEA MEVSLDITAL SILQQPEKLQ WEIVANVLED TVKDLEELGA
     NPCLTNSKSE KTKEKHQEQH NIPFPCLLAG GLLTYKSPAT SPISSNSHRS LDGLSRTQGE
     SISEQGSTDN ESCTNSELNS PLVRRTLPVL LLYSIKESDE KAGKIFSQMN NIMSKSLHDD
     GFTVPQIIEM ELDSQEQLLL QDPPVTYIQQ FADAAANLTS PDSEKWNSVF PKPGTLVQCL
     RLPKFAEEEN LCIDSITPCA DGIHLLVGLR TCPVESLSAI NQVEALNNLN KLNSALCNRR
     KGELESNLAV VNGANISVIQ HESPADVQTP LIIQPEQRNV SGGYLVLYKM NYATRIVTLE
     EEPIKIQHIK DPQDTITSLI LLPPDILDNR EDDCEEPIED MQLTSKNGFE REKTSDISTL
     GHLVITTQGG YVKILDLSNF EILAKVEPPK KEGTEEQDTF VSVIYCSGTD RLCACTKGGE
     LHFLQIGGTC DDIDEADILV DGSLSKGIEP SSEGSKPLSN PSSPGISGVD LLVDQPFTLE
     ILTSLVELTR FETLTPRFSA TVPPCWVEVQ QEQQQRRHPQ HLHQQHHGDA AQHTRTWKLQ
     TDSNSWDEHV FELVLPKACM VGHVDFKFVL NSNITNIPQI QVTLLKNKAP GLGKVNALNI
     EVEQNGKPSL VDLNEEMQHM DVEESQCLRL CPFLEDHKED ILCGPVWLAS GLDLSGHAGM
     LTLTSPKLVK GMAGGKYRSF LIHVKAVNER GTEEICNGGM RPVVRLPSLK HQSNKGYSLA
     SLLAKVAAGK EKSSNVKNEN TSGTRKSENL RGCDLLQEVS VTIRRFKKTS ISKERVQRCA
     MLQFSEFHEK LVNTLCRKTD DGQITEHAQS LVLDTLCWLA GVHSNGPGSS KEGNENLLSK
     TRKFLSDIVR VCFFEAGRSI AHKCARFLAL CISNGKCDPC QPAFGPVLLK ALLDNMSFLP
     AATTGGSVYW YFVLLNYVKD EDLAGCSTAC ASLLTAVSRQ LQDRLTPMEA LLQTRYGLYS
     SPFDPVLFDL EMSGSSCKNV YNSSIGVQSD EIDLSDVLSG NGKVSSCTAA EGSFTSLTGL
     LEVEPLHFTC VSTSDGTRIE RDDAMSSFGV TPAVGGLSSG TVGEASTALS SAAQVALQSL
     SHAMASAEQQ LQVLQEKQQQ LLKLQQQKAK LEAKLHQTTA AAAAAASAVG PVHNSVPSNP
     VAAPGFFIHP SDVIPPTPKT TPLFMTPPLT PPNEAVSVVI NAELAQLFPG SVIDPPAVNL
     AAHNKNSNKS RMNPLGSGLA LAISHASHFL QPPPHQSIII ERMHSGARRF VTLDFGRPIL
     LTDVLIPTCG DLASLSIDIW TLGEEVDGRR LVVATDISTH SLILHDLIPP PVCRFMKITV
     IGRYGSTNAR AKIPLGFYYG HTYILPWESE LKLMHDPLKG EGESANQPEI DQHLAMMVAL
     QEDIQCRYNL ACHRLETLLQ SIDLPPLNSA NNAQYFLRKP DKAVEEDSRV FSAYQDCIQL
     QLQLNLAHNA VQRLKVALGA SRKMLSETSN PEDLIQTSST EQLRTIIRYL LDTLLSLLHA
     SNGHSVPAVL QSTFHAQACE ELFKHLCISG TPKIRLHTGL LLVQLCGGER WWGQFLSNVL
     QELYNSEQLL IFPQDRVFML LSCIGQRSLS NSGVLESLLN LLDNLLSPLQ PQLPMHRRTE
     GVLDIPMISW VVMLVSRLLD YVATVEDEAA AAKKPLNGNQ WSFINNNLHT QSLNRSSKGS
     SSLDRLYSRK IRKQLVHHKQ QLNLLKAKQK ALVEQMEKEK IQSNKGSSYK LLVEQAKLKQ
     ATSKHFKDLI RLRRTAEWSR SNLDTEVTTA KESPEIEPLP FTLAHERCIS VVQKLVLFLL
     SMDFTCHADL LLFVCKVLAR IANATRPTIH LCEIVNEPQL ERLLLLLVGT DFNRGDISWG
     GAWAQYSLTC MLQDILAGEL LAPVAAEAME EGTVGDDVGA TAGDSDDSLQ QSSVQLLETI
     DEPLTHDITG APPLSSLEKD KEIDLELLQD LMEVDIDPLD IDLEKDPLAA KVFKPISSTW
     YDYWGADYGT YNYNPYIGGL GIPVAKPPAN TEKNGSQTVS VSVSQALDAR LEVGLEQQAE
     LMLKMMSTLE ADSILQALTN TSPTLSQSPT GTDDSLLGGL QAANQTSQLI IQLSSVPMLN
     VCFNKLFSML QVHHVQLESL LQLWLTLSLN SSSTGNKENG ADIFLYNANR IPVISLNQAS
     ITSFLTVLAW YPNTLLRTWC LVLHSLTLMT NMQLNSGSSS AIGTQESTAH LLVSDPNLIH
     VLVKFLSGTS PHGTNQHSPQ VGPTATQAMQ EFLTRLQVHL SSTCPQIFSE FLLKLIHILS
     TERGAFQTGQ GPLDAQVKLL EFTLEQNFEV VSVSTISAVI ESVTFLVHHY ITCSDKVMSR
     SGSDSSVGAR ACFGGLFANL IRPGDAKAVC GEMTRDQLMF DLLKLVNILV QLPLSGNREY
     SARVSVTTNT TDSVSDEEKV SGGKDGNGSS TSVQGSPAYV ADLVLANQQI MSQILSALGL
     CNSSAMAMII GASGLHLTKH ENFHGGLDAI SVGDGLFTIL TTLSKKASTV HMMLQPILTY
     MACGYMGRQG SLATCQLSEP LLWFILRVLD TSDALKAFHD MGGVQLICNN MVTSTRAIVN
     TARSMVSTIM KFLDSGPNKA VDSTLKTRIL ASEPDNAEGI HNFAPLGTIT SSSPTAQPAE
     VLLQATPPHR RARSAAWSYI FLPEEAWCDL TIHLPAAVLL KEIHIQPHLA SLATCPSSVS
     VEVSADGVNM LPLSTPVVTS GLTYIKIQLV KAEVASAVCL RLHRPRDAST LGLSQIKLLG
     LTAFGTTSSA TVNNPFLPSE DQVSKTSIGW LRLLHHCLTH ISDLEGMMAS AAAPTANLLQ
     TCAALLMSPY CGMHSPNIEV VLVKIGLQST RIGLKLIDIL LRNCAASGSD PTDLNSPLLF
     GRLNGLSSDS TIDILYQLGT TQDPGTKDRI QALLKWVSDS ARVAAMKRSG RMNYMCPNSS
     TVEYGLLMPS PSHLHCVAAI LWHSYELLVE YDLPALLDQE LFELLFNWSM SLPCNMVLKK
     AVDSLLCSMC HVHPNYFSLL MGWMGITPPP VQCHHRLSMT DDSKKQDLSS SLTDDSKNAQ
     APLALTESHL ATLASSSQSP EAIKQLLDSG LPSLLVRSLA SFCFSHISSS ESIAQSIDIS
     QDKLRRHHVP QQCNKMPITA DLVAPILRFL TEVGNSHIMK DWLGGSEVNP LWTALLFLLC
     HSGSTSGSHN LGAQQTSARS ASLSSAATTG LTTQQRTAIE NATVAFFLQC ISCHPNNQKL
     MAQVLCELFQ TSPQRGNLPT SGNISGFIRR LFLQLMLEDE KVTMFLQSPC PLYKGRINAT
     SHVIQHPMYG AGHKFRTLHL PVSTTLSDVL DRVSDTPSIT AKLISEQKDD KEKKNHEEKE
     KVKAENGFQD NYSVVVASGL KSQSKRAVSA TPPRPPSRRG RTIPDKIGST SGAEAANKII
     TVPVFHLFHK LLAGQPLPAE MTLAQLLTLL YDRKLPQGYR SIDLTVKLGS RVITDPSLSK
     TDSYKRLHPE KDHGDLLASC PEDEALTPGD ECMDGILDES LLETCPIQSP LQVFAGMGGL
     ALIAERLPML YPEVIQQVSA PVVTSTTQEK PKDSDQFEWV TIEQSGELVY EAPETVAAEP
     PPIKSAVQTM SPIPAHSLAA FGLFLRLPGY AEVLLKERKH AQCLLRLVLG VTDDGEGSHI
     LQSPSANVLP TLPFHVLRSL FSTTPLTTDD GVLLRRMALE IGALHLILVC LSALSHHSPR
     VPNSSVNQTE PQVSSSHNPT STEEQQLYWA KGTGFGTGST ASGWDVEQAL TKQRLEEEHV
     TCLLQVLASY INPVSSAVNG EAQSSHETRG QNSNALPSVL LELLSQSCLI PAMSSYLRND
     SVLDMARHVP LYRALLELLR AIASCAAMVP LLLPLSTENG EEEEEQSECQ TSVGTLLAKM
     KTCVDTYTNR LRSKRENVKT GVKPDASDQE PEGLTLLVPD IQKTAEIVYA ATTSLRQANQ
     EKKLGEYSKK AAMKPKPLSV LKSLEEKYVA VMKKLQFDTF EMVSEDEDGK LGFKVNYHYM
     SQVKNANDAN SAARARRLAQ EAVTLSTSLP LSSSSSVFVR CDEERLDIMK VLITGPADTP
     YANGCFEFDV YFPQDYPSSP PLVNLETTGG HSVRFNPNLY NDGKVCLSIL NTWHGRPEEK
     WNPQTSSFLQ VLVSVQSLIL VAEPYFNEPG YERSRGTPSG TQSSREYDGN IRQATVKWAM
     LEQIRNPSPC FKEVIHKHFY LKRVEIMAQC EEWIADIQQY SSDKRVGRTM SHHAAALKRH
     TAQLREELLK LPCPEGLDPD TDDAPEVCRA TTGAEETLMH DQVKPSSSKE LPSDFQL
//
